---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-030312"
form_type: "8-K"
ticker: "BJDX"
cik: "0001704287"
company_name: "Bluejay Diagnostics, Inc."
filed_at: "2025-04-09T23:59:59+00:00"
generated_at: "2026-05-23T18:25:00.495248+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Bluejay Diagnostics raises ~$3.7M via warrant inducement; existing holders exercise at reduced price

## Summary
- Entered inducement agreements to exercise 1,085,106 Class C warrants at reduced exercise price of $3.42/share (down from $16.30).
- Gross proceeds ~$3.7M; issued new Class E warrants for 1,085,106 shares exercisable at $3.42 through April 8, 2030.
- Issued 682,203 common shares at closing; pre-funded warrants for 402,903 shares to avoid beneficial ownership limits.
- Paid Aegis Capital Corp. $385,000 financial advisory fee; transaction closed April 8, 2025.

## SEC filing metadata
- accession: 0001213900-25-030312
- form_type: 8-K
- ticker: BJDX
- cik: 0001704287
- company_name: Bluejay Diagnostics, Inc.
- filed_at: 2025-04-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1704287/000121390025030312/0001213900-25-030312-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1704287/000121390025030312/ea0237671-8k_bluejay.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-030312
- JSON: https://secwatch.observer/filing/0001213900-25-030312.json
- Plain text: https://secwatch.observer/filing/0001213900-25-030312.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.